ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Boston Biotech & Pharma IT Infrastructure & AI Integration Consulting Expanded

GAMMA SOLUTIONS LLC, a next-generation IT consulting provider, has announced the expansion of their services into the pharma and biotech markets in Boston.

-- Following this expansion, the fledgling consultancy will be providing their services as knowledgeable experts in the areas of digital strategy, process and systems optimization, systems integration, and more. As they explain on their website, they are excited to apply their signature hands-on, progress-focused approach in the Boston area.

For more, visit https://www.gamma-solutions.llc/

The company chose biotech as the next frontier for their ongoing expansion due to the remarkable rate at which that sector is growing. Boston, in particular, is shaping up to be among the largest biotech hubs in the country. With a nationwide CAGR exceeding 8.5%, a number which Yahoo Finance called “staggering”, there is a clear need for even-handed, technology-focused guidance in the industry that GAMMA SOLUTIONS, LLC now intends to fill.

To do so, they will be offering “CTO-level insights” and strategic planning services to help solve technological and organizational challenges for their clients.

Most recently, the consultancy has ramped up their AI implementation services, given the rapid advancement of that technology into the medical sector and the highly promising results that companies have seen so far. They offer guidance on the ethical and practical limitations of the technology, ensuring that AI and machine learning can be used appropriately, and to maximum effect.

The company is owned and operated by Montreal native industry mainstay Gilles-André Morin, known to many simply as G.-A. His career and expertise in IT have taken him to a wide range of industries, assisting hundreds of prominent companies through difficult phases of growth. Now, he is bringing that skillset to the biotech and pharmaceutical industries under the GAMMA SOLUTIONS banner.

To read more about him, visit https://www.linkedin.com/in/gamorin/

Over half a dozen case studies and counting are available to peruse on the GAMMA SOLUTIONS website, each detailing a unique, highly specific example of their team’s agility and commitment to customer success. Thus far, they have successfully worked with mid-market and large companies, delivering beneficial resolutions in virtually all cases, according to their own reporting.

While Gilles-André’s reputation precedes him, the company itself launched recently, and further service expansions are planned for the near future. Those in the Boston biotech and pharma industries interested in partnering with GAMMA for IT projects at any scale should contact their team at the link below.

Learn more at https://www.gamma-solutions.llc/services

Contact Info:
Name: Gilles-Andre' Morin
Email: Send Email
Organization: GAMMA SOLUTIONS, LLC
Address: 45 Nonantum St., Newton, MA 02458, United States
Website: https://www.gamma-solutions.llc

Source: PressCable

Release ID: 89165168

If there are any problems, discrepancies, or queries related to the content presented in this press release, we kindly ask that you notify us immediately at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be available round-the-clock to address your concerns within 8 hours and take necessary actions to rectify any identified issues or support you with press release takedowns. Ensuring accurate and trustworthy information is our unwavering commitment.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  230.82
-1.71 (-0.74%)
AAPL  271.86
-1.22 (-0.45%)
AMD  214.16
-1.18 (-0.55%)
BAC  55.00
-0.28 (-0.51%)
GOOG  313.80
-0.75 (-0.24%)
META  660.09
-5.86 (-0.88%)
MSFT  483.62
-3.86 (-0.79%)
NVDA  186.50
-1.04 (-0.55%)
ORCL  194.91
-2.30 (-1.17%)
TSLA  449.72
-4.71 (-1.04%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.